Progress and prospects: biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors (Q37445505)

20 August 2017

1 reference

title

Progress and prospects: biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors (English)

1 reference

20 August 2017

0 references

1 reference

A L Epstein

1

1 reference

20 August 2017

publication date

16 April 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

16

1 reference

20 August 2017

issue

6

1 reference

20 August 2017

page(s)

709-715

1 reference

HSV-1 amplicon vectors: a promising and versatile tool for gene delivery.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Stable transgene expression from HSV amplicon vectors in the brain: potential involvement of immunoregulatory signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Plasmid DNA sequences present in conventional herpes simplex virus amplicon vectors cause rapid transgene silencing by forming inactive chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Hexamethylene bisacetamide leads to reduced helper virus-free HSV-1 amplicon expression titers via suppression of ICP0.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Glutamatergic or GABAergic neuron-specific, long-term expression in neocortical neurons from helper virus-free HSV-1 vectors containing the phosphate-activated glutaminase, vesicular glutamate transporter-1, or glutamic acid decarboxylase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Improvement in reproductive parameters in hypogonadal female mice by regulated gene replacement therapy in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Infectious Delivery and Expression of a 135 kb Human FRDA Genomic DNA Locus Complements Friedreich's Ataxia Deficiency in Human Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Targeting proliferating tumor cells via the transcriptional control of therapeutic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Engineering an improved cell cycle-regulatable herpes simplex virus type 1 amplicon vector with enhanced transgene expression in proliferating cells yet attenuated activities in resting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Chimeric herpes simplex virus/adeno-associated virus amplicon vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Efficient site-specific integration of large transgenes by an enhanced herpes simplex virus/adeno-associated virus hybrid amplicon vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Expression of human ATM cDNA in Atm-deficient mouse brain mediated by HSV-1 amplicon vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Targeted integration of functional human ATM cDNA into genome mediated by HSV/AAV hybrid amplicon vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Neuronal precursor-restricted transduction via in utero CNS gene delivery of a novel bipartite HSV amplicon/transposase hybrid vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Neuronal specificity of HSV/sleeping beauty amplicon transduction in utero is driven primarily by tropism and cell type composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Advances in high-capacity extrachromosomal vector technology: episomal maintenance, vector delivery, and transgene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

A novel human artificial chromosome gene expression system using herpes simplex virus type 1 vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

HSV-1 amplicon viral vector-mediated gene transfer to human bone marrow-derived mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

HSV amplicons: neuro applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

HSV amplicon vectors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Amplicon vectors as outstanding tools to study and modify cognitive functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

HSV-1 based amplicon vectors as an alternative system for the expression of functional HCV proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Amplicons as vaccine vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Switching on the lights for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Bioluminescence imaging after HSV amplicon vector delivery into brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

Early STAT1 activation after systemic delivery of HSV amplicon vectors suppresses transcription of the vector-encoded transgene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

7 January 2021

inferred from DOI database lookup

An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomas.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

7 January 2021

inferred from DOI database lookup

Multitracer positron emission tomographic imaging of exogenous gene expression mediated by a universal herpes simplex virus 1 amplicon vector.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2009.42

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/GT.2009.42

1 reference

release_btnbzuyp6bhgbnljaagni7wcqm

20 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/btnbzuyp6bhgbnljaagni7wcqm

24 November 2022

mapped directly with Wikidata item

1 reference